BMRN Next Earnings Date Notes

— BioMarin Pharmaceutical Inc. (BMRN) is a global biotechnology company specializing in developing & commercializing innovative therapies for rare genetic diseases, with a portfolio including enzyme replacement therapies and gene therapies such as Vimizim, Naglazyme, and Voxzogo. For investors tracking BMRN's performance, the most relevant business metrics are commercial product revenue growth (especially for key therapies like Voxzogo), pipeline progress—including clinical trial updates & regulatory milestones for late-stage candidates—and gross margins, reflecting operational efficiency. Pay particular attention to total revenue guidance, new patient starts, geographic expansion (notably international market penetration), and updates on clinical pipeline assets like Roctavian (hemophilia A gene therapy). Also, monitor R&D spending trends relative to advancing pipeline programs and any forward-looking commentary regarding product launches or market exclusivity. The combination of robust sales trajectory for approved products & meaningful progress in late-clinical pipeline programs are critical to BioMarin's long-term success, so these topics are likely to feature prominently on the upcoming earnings call. The next projected earnings date for BMRN is 8/3/2026 after close (stay tuned for a confirmed earnings date once announced).

BMRN Next Earnings Date FAQ

On this page we presented the BMRN Next Earnings Date information for Biomarin Pharmaceutical along with recent past earnings dates. For Q1 of 2026, BMRN reported earnings of 0.760/share, with the earnings report taking place on 5/4/2026. For Q4 of 2025, BMRN reported earnings of 0.460/share, with the earnings report taking place on 2/23/2026. For Q3 of 2025, BMRN reported earnings of 0.120/share, with the earnings report taking place on 10/27/2025. For Q2 of 2025, BMRN reported earnings of 1.440/share, with the earnings report taking place on 8/4/2025. For Q1 of 2025, BMRN reported earnings of 1.130/share, with the earnings report taking place on 5/1/2025. Based on these past earnings dates, the projected next earnings date for BMRN is 8/3/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Biomarin Pharmaceutical. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Biomarin Pharmaceutical shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Biomarin Pharmaceutical next earnings dates as well as any other stock out there in our coverage universe, to see when the next BMRN earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up BMRN's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the BMRN next earnings date.